You haven't searched anything yet.
Company Overview
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s two lead programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company’s proprietary product engine, FulcrumSeekTM, identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression.
Description
This role reports to the Head of Biometrics. The Director, Clinical Data Management (CDM), will provide data management support to clinical studies within the Biometrics function, and would be responsible for all CDM related areas/activities for clinical studies assigned.
Responsibilities
Qualifications
Personal Characteristics
Full Time
Pharmaceutical
$151k-184k (estimate)
02/29/2024
04/28/2024
fulcrumtx.com
CAMBRIDGE, MA
50 - 100
2016
ROBERT J GOULD
$5M - $10M
Pharmaceutical
We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Community Guidelines: https://bit.ly/3t2xeR9